Éva Balázs

771 total citations
13 papers, 468 citations indexed

About

Éva Balázs is a scholar working on Neurology, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Éva Balázs has authored 13 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Rheumatology. Recurrent topics in Éva Balázs's work include Neurological disorders and treatments (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Éva Balázs is often cited by papers focused on Neurological disorders and treatments (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Éva Balázs collaborates with scholars based in Hungary, United States and Poland. Éva Balázs's co-authors include Norbert Kovács, Zsuzsanna Aschermann, Sámuel Komoly, Endre Pál, József Janszky, Ferenc Nagy, Katalin Takács, Kázmér Karádi, Gabriella Deli and Péter Ács and has published in prestigious journals such as Journal of the American College of Cardiology, Annals of the Rheumatic Diseases and American Heart Journal.

In The Last Decade

Éva Balázs

12 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Éva Balázs Hungary	7	354	175	65	64	61	13	468
Nebil Yıldız Türkiye	13	195 0.6×	70 0.4×	56 0.9×	48 0.8×	68 1.1×	34	486
David Czell Switzerland	13	345 1.0×	53 0.3×	69 1.1×	18 0.3×	52 0.9×	31	528
Timea Hodics United States	8	130 0.4×	87 0.5×	57 0.9×	74 1.2×	54 0.9×	15	341
Gharib Fawi Egypt	12	77 0.2×	121 0.7×	46 0.7×	82 1.3×	63 1.0×	20	329
Samuel T. Nemanich United States	13	91 0.3×	125 0.7×	63 1.0×	41 0.6×	136 2.2×	32	362
Mauro Catalan Italy	11	128 0.4×	38 0.2×	29 0.4×	55 0.9×	74 1.2×	27	349
Rick van der Vliet Netherlands	11	68 0.2×	110 0.6×	47 0.7×	109 1.7×	45 0.7×	14	357
Victor M. Borges New Zealand	6	120 0.3×	107 0.6×	53 0.8×	68 1.1×	60 1.0×	7	407
Priscila Nóbrega‐Sousa Brazil	9	117 0.3×	111 0.6×	126 1.9×	97 1.5×	59 1.0×	15	342
Núbia Ribeiro da Conceição Brazil	9	108 0.3×	110 0.6×	125 1.9×	96 1.5×	54 0.9×	15	332

Countries citing papers authored by Éva Balázs

Since Specialization

Citations

This map shows the geographic impact of Éva Balázs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éva Balázs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éva Balázs more than expected).

Fields of papers citing papers by Éva Balázs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éva Balázs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éva Balázs. The network helps show where Éva Balázs may publish in the future.

Co-authorship network of co-authors of Éva Balázs

This figure shows the co-authorship network connecting the top 25 collaborators of Éva Balázs. A scholar is included among the top collaborators of Éva Balázs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éva Balázs. Éva Balázs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Genovese, Mark C., Juan Sánchez‐Bursón, Myungshin Oh, et al.. (2020). Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis. Arthritis Research & Therapy. 22(1). 60–60. 15 indexed citations

Westhovens, René, Dae‐Hyun Yoo, Piotr Wiland, et al.. (2020). THU0186 CLINICAL EVALUATION OF THE IMMUNOGENICITY TO CT-P13 FOR SUBCUTANEOUS USE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 1-YEAR CLINICAL RESULTS FROM A MULTICENTER, RANDOMIZED CONTROLLED PIVOTAL TRIAL. Annals of the Rheumatic Diseases. 79. 310–311. 1 indexed citations

Genovese, Mark C., Juan Sánchez‐Bursón, Myungshin Oh, et al.. (2019). AB0377 CLINICAL SIMILARITY OF ABP 710 WITH INFLIXIMAB (REFERENCE PRODUCT) IN SUBJECTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 78. 1648–1649. 1 indexed citations

Westhovens, René, Piotr Wiland, Marek Zawadzki, et al.. (2019). SAT0170 A NOVEL FORMULATION OF CT-P13 FOR SUBCUTANEOUS ADMINISTRATION: 30 WEEK RESULTS FROM A PART 2 OF PHASE I/III RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 78. 1158–1159. 5 indexed citations

Makkos, Attila, Endre Pál, Zsuzsanna Aschermann, et al.. (2016). High-Frequency Repetitive Transcranial Magnetic Stimulation Can Improve Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study. Neuropsychobiology. 73(3). 169–177. 51 indexed citations

Horváth, Krisztina, Zsuzsanna Aschermann, Péter Ács, et al.. (2015). Minimal clinically important difference on the Motor Examination part of MDS-UPDRS. Parkinsonism & Related Disorders. 21(12). 1421–1426. 212 indexed citations

Pál, Endre, Ferenc Nagy, Zsuzsanna Aschermann, Éva Balázs, & Norbert Kovács. (2010). The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double‐blind, placebo‐controlled study. Movement Disorders. 25(14). 2311–2317. 132 indexed citations

Deli, Gabriella, István Balás, Ferenc Nagy, et al.. (2010). Comparison of the efficacy of unipolar and bipolar electrode configuration during subthalamic deep brain stimulation. Parkinsonism & Related Disorders. 17(1). 50–54. 24 indexed citations

Balás, István, Sámuel Komoly, Tamás Dóczi, et al.. (2010). [Analysis of antiparkinsonian drug reduction after bilateral subthalamic deep brain stimulation].. PubMed. 63(9-10). 314–9. 11 indexed citations

10.

Bexell, Daniel, Randolph M. Setser, Paul Schoenhagen, et al.. (2008). Influence of Coronary Artery Stenosis Severity and Coronary Collateralization on Extent of Chronic Myocardial Scar: Insights from Quantitative Coronary Angiography and Delayed-Enhancement MRI. The Open Cardiovascular Medicine Journal. 2(1). 79–86. 5 indexed citations

11.

Ivanc, Thomas B., et al.. (1999). Corrected TIMI frame count does not predict 30-day adverse outcomes after reperfusion therapy for acute myocardial infarction. American Heart Journal. 138(4). 785–790. 7 indexed citations

12.

Ivanc, Thomas B., et al.. (1998). Reproducibility of the corrected TIMI frame count in angiograms of MI patients receiving thrombolysis. Journal of the American College of Cardiology. 31. 11–12. 3 indexed citations

13.

Balázs, Éva. (1984). Journal of a hospice worker. American Journal of Hospice Care. 1(3). 35–39. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact